April 29, 2019, PARIS – KEEN EYE, a company that designs, develops and markets machine learning solutions for the research and biomedical sectors, announces today that it has finalized a EUR 6 million fundraising led by CM-CIC Innovation and with the Quadrivium 1 Seeding Fund, managed by Seventure Partners, its historical partner.
HalioDx and Keen Eye partner to empower IMMUNOSCORE® with AI
November 8, 2018, PARIS – HalioDx, an immuno-oncology diagnostic company pioneering the immunological diagnosis of cancers with Immunoscore® and Keen Eye, an innovative company specialized in image analysis technologies based on artificial intelligence announced today a strategic partnership to develop a cloud-based platform (...).
Iris Pharma and Keen Eye team up to bring AI in ophthalmology studies
October 2018, PARIS – Keen Eye, a French technology company specialized in image analysis for the life science industry, announced today a strategic partnership agreement with Iris Pharma, a world-wide leading ophthalmology-focused contract research organization (CRO) that offers preclinical and clinical drug / device development services.
Keen Eye raises €1.5 Million from Seventure Partners’ Quadrivium 1 seed fund
December 12, 2016, PARIS – Keen Eye will finalize the development of its innovative image interpretation platform for laboratories and biomedical research Keen Eye, a company that designs, develops and markets innovative image analysis solutions for research and the medical sector, announced today a 1.5 million fund raising from Seventure Partners’ Quadrivium seed fund.